🚀 VC round data is live in beta, check it out!

Hinge Health Valuation Multiples

Discover revenue and EBITDA valuation multiples for Hinge Health and similar public comparables like Brookdale Senior Living, Privia Health, National Healthcare Corp, Emeis and more.

Hinge Health Overview

About Hinge Health

Hinge Health Inc is a technology platform for individuals seeking to treat and prevent joint and muscle pain. Through a combination of AI-powered motion tracking technology, the Company’s platform helps members address musculoskeletal (MSK) conditions, enables improved member outcomes and supports cost reductions for its clients. The Company’s clients are self-insured employers.


Founded

2016

HQ

United States

Employees

N/A

Financials (LTM)

Revenue: $638M
EBITDA: $133M

EV

$3B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Hinge Health Financials

Hinge Health reported last 12-month revenue of $638M and EBITDA of $133M.

In the same LTM period, Hinge Health generated $527M in gross profit, $133M in EBITDA, and had net loss of ($329M).

Revenue (LTM)


Hinge Health P&L

In the most recent fiscal year, Hinge Health reported revenue of $588M and EBITDA of ($541M).

Hinge Health is unprofitable as of last fiscal year, with gross margin of 80%, EBITDA margin of (92%), and net margin of (90%).

See analyst estimates for Hinge Health
LTMLast FY202320242025202620272028
Revenue$638M$588M$293M$390M$588M
Gross Profit$527M$468M$194M$300M$468M
Gross Margin83%80%66%77%80%
EBITDA$133M($541M)($125M)($26M)($541M)
EBITDA Margin21%(92%)(43%)(7%)(92%)
EBIT Margin21%(93%)(45%)(8%)(93%)
Net Profit($329M)($528M)($108M)($12M)($528M)
Net Margin(52%)(90%)(37%)(3%)(90%)

Financial data powered by Morningstar, Inc.

Hinge Health Stock Performance

Hinge Health has current market cap of $3B, and enterprise value of $3B.

Market Cap Evolution


Hinge Health's stock price is $44.60.

Hinge Health share price increased by 14.8% in the last year.

Hinge Health has an EPS (earnings per share) of $-6.83.

See more trading valuation data for Hinge Health
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$3B$3B1.4%—-15.0%14.8%$-6.83

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Hinge Health Valuation Multiples

Hinge Health trades at 5.2x EV/Revenue multiple, and 24.8x EV/EBITDA.

See NTM and 2027E valuation multiples for Hinge Health

EV / Revenue (LTM)


Hinge Health Financial Valuation Multiples

As of May 1, 2026, Hinge Health has market cap of $3B and EV of $3B.

Hinge Health has a P/E ratio of (10.5x).

LTMLast FY202320242025202620272028
EV/Revenue5.2x5.6x11.3x8.4x5.6x
EV/EBITDA24.8x(6.1x)(26.4x)(126.9x)(6.1x)
EV/EBIT25.1x(6.0x)(25.2x)(103.3x)(6.0x)
EV/Gross Profit6.3x7.0x17.0x11.0x7.0x
P/E(10.5x)(6.5x)(31.9x)n/m(6.5x)
EV/FCF17.2x19.9x(48.1x)72.8x19.9x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Hinge Health Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Hinge Health Margins & Growth Rates

In the most recent fiscal year, Hinge Health reported gross margin of 80%, EBITDA margin of (92%), and net margin of (90%).

See estimated margins and future growth rates for Hinge Health

Hinge Health Margins

Last FY20242025202720282029
Gross Margin80%77%80%
EBITDA Margin(92%)(7%)(92%)
EBIT Margin(93%)(8%)(93%)
Net Margin(90%)(3%)(90%)
FCF Margin28%12%28%

Hinge Health Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth33%51%
Gross Profit Growth54%56%
EBITDA Growth(79%)1985%
EBIT Growth(76%)1612%
Net Profit Growth(89%)4327%
FCF Growth(166%)266%

Data powered by FactSet, Inc. and Morningstar, Inc.

Hinge Health Operational KPIs

Access forward-looking KPIs for Hinge Health
LTMLast FY202320242025202620272028
Rule of 4044%————
Bessemer Rule of X79%————
S&M Expenses to Revenue36%54%50%43%54%
G&A Expenses to Revenue12%56%23%16%56%
R&D Expenses to Revenue15%63%38%26%63%
Opex to Revenue—173%111%85%173%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Hinge Health Competitors

Hinge Health competitors include Brookdale Senior Living, Privia Health, National Healthcare Corp, Emeis, Extendicare, GeneDx, Sienna Senior Living, Addus HomeCare, XtalPi and Caris Life Sciences.

Most Hinge Health public comparables operate across Long-Term Care and Health Data & Analytics.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Brookdale Senior Living2.7x2.8x25.2x18.3x
Privia Health1.2x1.2x21.1x19.8x
National Healthcare Corp1.7x—11.9x—
Emeis1.7x1.6x13.1x11.2x
Extendicare1.7x1.5x15.1x14.4x
GeneDx4.2x3.8x44.1x49.2x
Sienna Senior Living3.7x3.5x23.1x21.5x
Addus HomeCare1.3x1.3x10.5x10.3x

This data is available for Pro users. Sign up to see all Hinge Health competitors and their valuation data.

Start Free Trial

Hinge Health Funding History

Before going public, Hinge Health raised $1B in total equity funding, across 8 rounds.

Last private valuation of Hinge Health was $6B, after raising $200M in October 2021 from Alkeon Capital and Whale Rock Capital Management.


Hinge Health Funding Rounds

DateStageRaised FromRaisedValuationRev. MultipleDeal Summary
Oct-21Secondary - privateAlkeon Capital; Whale Rock Capital Management$200M$6BHinge Health is a digital musculoskeletal (MSK) healthcare platform that provides virtual physical therapy, AI-powered motion tracking, wearable sensors, and health coaching to treat back and joint pain. The company was founded in 2014 and has partnerships with major employers including Boeing, Google, Salesforce, and Verizon. In October 2021, Hinge Health announced a $400 million Series E funding round led by Tiger Global and Coatue Management at a $6.2 billion valuation. As part of the same financing event, Alkeon Capital and Whale Rock Capital Management made a $200 million secondary investment to acquire ownership stakes in the company. By the time of this funding, Hinge Health had more than doubled its customer base year-over-year to over 575 enterprise customers and had raised over $1 billion cumulatively across all rounds. The company subsequently went public on the New York Stock Exchange in May 2025 at $32 per share, raising approximately $273 million in fresh capital.
Oct-21Series ECoatue; IP Group; TCV; Tiger Global$400M$6BHinge Health, a San Francisco-based digital health company, provides virtual physical therapy and digital solutions for chronic musculoskeletal (MSK) conditions like back and joint pain, using advanced wearable sensors, computer vision technology, and a clinical team of physical therapists, physicians, and health coaches to reduce pain, surgeries, and opioid use. On October 28, 2021, Hinge Health closed a $400 million Series E funding round led by existing investors Coatue Management and Tiger Global, with participation from new investors Alkeon Capital and Whale Rock Capital, the latter providing a $200 million secondary investment. The round valued the company at $6.2 billion post-money, more than doubling the $3 billion valuation from its January 2021 $300 million Series D round also co-led by Coatue and Tiger Global. Total funding raised reached over $1 billion, including approximately $454 million from earlier rounds. The investment supports expansion of digital MSK clinic offerings, enhancement of wearable and sensor technology, scaling of client partnerships, and further technology and product development to improve access, outcomes, and patient experiences. At the time, Hinge Health had more than doubled its customer base year-over-year to over 575 enterprise customers, including major employers like Boeing, Salesforce, Verizon, and organizations such as the State of New Jersey, and was used by four in five employers and 90% of health plans offering digital MSK solutions. The company was approaching 1,000 employees and had recently hired key executives including CTO Lalith Vadlamannati from Amazon and Chief People Officer Vincent Lim from Google, Medium, and JUUL. Hinge Health positioned itself as one of the most valuable private digital health companies, with over $1 billion invested to build one of the largest clinical, data science, and R&D teams in the sector.
Jan-21Series D11.2 Capital; Atomico; Bessemer Venture Partners; Coatue; Counterpart Advisors; Heuristic Capital; Insight Partners; Lead Edge Capital; Quadrille Capital; Tiger Global$300M$3B—
Feb-20Series C11.2 Capital; Atomico; Bessemer Venture Partners; Heuristic Capital; Insight Partners; Lead Edge Capital; Quadrille Capital$90M$420M—
Aug-18Series BAtomico; Insight Partners$26M—Hinge Health, a San Francisco-based digital health startup founded in 2015, raised $26 million in a Series B funding round on August 9, 2018, led by Insight Venture Partners with participation from Series A investor Atomico. The company develops software, hardware, and services including wearable motion sensor bands and a tablet-based app to help employers manage employees' musculoskeletal (MSK) conditions like chronic back and joint pain. This brought total funding to $36 million. The platform targets self-insured employers and health plans, aiming to reduce medical costs associated with MSK disorders. At the time of the Series B, Hinge Health reported 40 enterprise customers in the U.S. and partnerships with 10 of the largest health plans. Clinical outcomes showed 2 in 3 patients avoiding surgery, improved from 1 in 2 during Series A, with a goal to reach 80 percent. The solution is positioned as a 'Digital Care Pathway' combining tech with human coaching to boost adherence, emphasizing trusted care team relationships over passive digital interventions. Later rounds provide context: Series C in April 2021 valued the company at $405 million post-$90 million raise; Series D in early 2022 at $3 billion post-$300 million; Series E in 2021 at $6.2 billion post-$400 million.
Jul-17Series A11.2 Capital; Atomico; Jon Reynolds; The Vertical Group$8M—Hinge Health is a San Francisco-based digital health platform specializing in musculoskeletal (MSK) pain treatment through a comprehensive solution combining physical therapy, wearable sensors, exercise programs, and behavioral support. In July 2017, the company closed an $8 million Series A round led by Atomico, with participation from existing investors Eleven Two Capital, The Vertical Group, and founder Jon Reynolds. At the time, Hinge Health was demonstrating significant clinical traction, with the company reporting 80% adherence rates through its 12-week program and having recently completed a Randomized Control Trial to validate efficacy. The startup was targeting self-insured employers and health plans in the United States, positioning its platform as a cost-reduction solution for the estimated $100 billion annual cost of workplace-related MSK disorders. By late 2017, Hinge Health had secured approximately $10 million in total funding and employed around 70 people, with plans to expand its clinical team and geographic footprint.
Jun-16Seed11.2 Capital; Jon Reynolds; The Vertical Group$1M——
Jan-16AngelDaniel Perez$500K——

Hinge Health M&A Activity

Hinge Health has acquired 2 companies to date.

Last acquisition by Hinge Health was on September 17th 2021. Hinge Health acquired wrnch for undisclosed valuation.

See M&A valuation multiples

Latest Acquisitions by Hinge Health

wrnch
ENSO
Description
wrnch is a Montréal-headquartered computer vision company specializing in real-time human pose estimation for AR applications. Its SDK powers interactive fitness mirrors and retail try-on experiences for clients in consumer electronics. Incubated by TandemLaunch, the firm delivers edge-deployable AI models trained on diverse datasets.
ENSO is a US-based medical device company offering an opioid-free wearable for chronic and acute pain relief. The FDA-cleared device delivers patented electrical stimulation via app control to relax muscles and calm nerves, outperforming Vicodin in clinical trials. Used at over 100 centers including Stanford, Harvard, and Cedars-Sinai, it gains coverage from VA hospitals and workers' compensation plans, with commercial insurance expected soon. Targeting 1.5 billion chronic pain sufferers globally, ENSO devices ship to patients nationwide.
HQ CountryCanadaUnited States
HQ City
Montreal
San Francisco, CA
Deal Date17 Sep 20219 Mar 2021
Valuationundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Hinge Health acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Hinge Health

When was Hinge Health founded?Hinge Health was founded in 2016.
Where is Hinge Health headquartered?Hinge Health is headquartered in United States.
Who is the CEO of Hinge Health?Hinge Health's CEO is Daniel Perez.
Is Hinge Health publicly listed?Yes, Hinge Health is a public company listed on NYSE.
What is the stock symbol of Hinge Health?Hinge Health trades under HNGE ticker.
When did Hinge Health go public?Hinge Health went public in 2025.
Who are competitors of Hinge Health?Hinge Health main competitors include Brookdale Senior Living, Privia Health, National Healthcare Corp, Emeis, Extendicare, GeneDx, Sienna Senior Living, Addus HomeCare, XtalPi, Caris Life Sciences.
What is the current market cap of Hinge Health?Hinge Health's current market cap is $3B.
What is the current revenue of Hinge Health?Hinge Health's last 12 months revenue is $638M.
What is the current revenue growth of Hinge Health?Hinge Health revenue growth (NTM/LTM) is 23%.
What is the current EV/Revenue multiple of Hinge Health?Current revenue multiple of Hinge Health is 5.2x.
Is Hinge Health profitable?Yes, Hinge Health is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Hinge Health?Hinge Health's last 12 months EBITDA is $133M.
What is Hinge Health's EBITDA margin?Hinge Health's last 12 months EBITDA margin is 21%.
What is the current EV/EBITDA multiple of Hinge Health?Current EBITDA multiple of Hinge Health is 24.8x.
What is the current FCF of Hinge Health?Hinge Health's last 12 months FCF is $192M.
What is Hinge Health's FCF margin?Hinge Health's last 12 months FCF margin is 30%.
What is the current EV/FCF multiple of Hinge Health?Current FCF multiple of Hinge Health is 17.2x.
How many companies Hinge Health has acquired to date?As of May 2026, Hinge Health has acquired 2 companies.
What was the largest acquisition by Hinge Health?None of the M&A deals Hinge Health has completed have disclosed valuations.
What companies Hinge Health acquired?Hinge Health acquired ENSO and wrnch.
In how many companies Hinge Health has invested to date?Hinge Health hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Hinge Health

Lists including Hinge Health

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial